Krensavage Asset Management, LLC Enanta Pharmaceuticals Inc Transaction History

Krensavage Asset Management, LLC

  • $218 Million
  • Q2 2024

A detailed history of Krensavage Asset Management, LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Krensavage Asset Management, LLC holds 1,251,338 shares of ENTA stock, worth $13.7 Million. This represents 7.45% of its overall portfolio holdings.

Number of Shares
1,251,338
Previous 1,124,586 11.27%
Holding current value
$13.7 Million
Previous $19.6 Million 17.34%
% of portfolio
7.45%
Previous 8.71%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$11.43 - $17.02 $1.45 Million - $2.16 Million
126,752 Added 11.27%
1,251,338 $16.2 Million
Q1 2024

May 15, 2024
BUY
$10.08 - $17.46 $3.85 Million - $6.67 Million
381,762 Added 51.39%
1,124,586 $19.6 Million
Q4 2023

Feb 14, 2024
BUY
$8.18 - $10.78 $63,157 - $83,232
7,721 Added 1.05%
742,824 $6.99 Million
Q3 2023

Nov 14, 2023
BUY
$11.09 - $22.13 $526,664 - $1.05 Million
47,490 Added 6.91%
735,103 $8.21 Million
Q2 2023

Aug 11, 2023
BUY
$20.68 - $39.85 $1.74 Million - $3.36 Million
84,312 Added 13.98%
687,613 $14.7 Million
Q1 2023

May 15, 2023
BUY
$38.82 - $54.59 $329,310 - $463,086
8,483 Added 1.43%
603,301 $24.4 Million
Q4 2022

Feb 15, 2023
BUY
$40.77 - $53.73 $222,522 - $293,258
5,458 Added 0.93%
594,818 $27.7 Million
Q3 2022

Nov 14, 2022
SELL
$48.29 - $71.27 $1.71 Million - $2.52 Million
-35,408 Reduced 5.67%
589,360 $30.6 Million
Q2 2022

Aug 16, 2022
BUY
$38.13 - $76.93 $2.9 Million - $5.84 Million
75,940 Added 13.84%
624,768 $29.5 Million
Q1 2022

May 17, 2022
SELL
$56.06 - $74.11 $856,260 - $1.13 Million
-15,274 Reduced 2.71%
548,828 $39.1 Million
Q4 2021

Feb 15, 2022
SELL
$60.19 - $97.37 $22.4 Million - $36.3 Million
-372,675 Reduced 39.78%
564,102 $42.2 Million
Q3 2021

Nov 16, 2021
SELL
$41.02 - $58.65 $117,850 - $168,501
-2,873 Reduced 0.31%
936,777 $53.2 Million
Q2 2021

Aug 13, 2021
BUY
$43.76 - $53.11 $3.36 Million - $4.08 Million
76,802 Added 8.9%
939,650 $41.4 Million
Q1 2021

May 18, 2021
BUY
$41.69 - $54.95 $168,302 - $221,833
4,037 Added 0.47%
862,848 $42.6 Million
Q4 2020

Feb 17, 2021
BUY
$41.16 - $47.47 $1.38 Million - $1.59 Million
33,482 Added 4.06%
858,811 $36.2 Million
Q3 2020

Nov 17, 2020
BUY
$43.36 - $53.53 $2.7 Million - $3.33 Million
62,226 Added 8.15%
825,329 $37.8 Million
Q2 2020

Aug 17, 2020
BUY
$46.37 - $57.58 $2.91 Million - $3.62 Million
62,785 Added 8.97%
763,103 $38.3 Million
Q1 2020

May 18, 2020
BUY
$40.22 - $62.0 $8.48 Million - $13.1 Million
210,933 Added 43.1%
700,318 $36 Million
Q4 2019

Feb 18, 2020
SELL
$57.95 - $66.61 $549,887 - $632,062
-9,489 Reduced 1.9%
489,385 $30.2 Million
Q3 2019

Nov 15, 2019
BUY
$60.08 - $88.17 $1.16 Million - $1.7 Million
19,298 Added 4.02%
498,874 $30 Million
Q2 2019

Aug 14, 2019
BUY
$81.3 - $97.35 $287,314 - $344,034
3,534 Added 0.74%
479,576 $40.5 Million
Q1 2019

May 15, 2019
SELL
$69.08 - $105.66 $4.06 Million - $6.21 Million
-58,783 Reduced 10.99%
476,042 $45.5 Million
Q4 2018

Feb 15, 2019
SELL
$65.41 - $84.65 $68,811 - $89,051
-1,052 Reduced 0.2%
534,825 $37.9 Million
Q4 2018

Feb 14, 2019
BUY
$65.41 - $84.65 $1.62 Million - $2.09 Million
24,691 Added 4.83%
535,877 $44.1 Million
Q3 2018

Nov 14, 2018
SELL
$85.46 - $126.37 $670,775 - $991,878
-7,849 Reduced 1.51%
511,186 $43.7 Million
Q2 2018

Aug 13, 2018
SELL
$81.85 - $120.51 $18.1 Million - $26.6 Million
-220,703 Reduced 29.84%
519,035 $60.2 Million
Q1 2018

May 14, 2018
SELL
$57.91 - $92.15 $7.36 Million - $11.7 Million
-127,032 Reduced 14.66%
739,738 $59.9 Million
Q4 2017

Feb 14, 2018
SELL
$45.65 - $59.37 $6.71 Million - $8.73 Million
-147,077 Reduced 14.51%
866,770 $50.9 Million
Q3 2017

Nov 14, 2017
BUY
$37.91 - $46.8 $38.4 Million - $47.4 Million
1,013,847
1,013,847 $47.4 Million

Others Institutions Holding ENTA

# of Institutions
101
Shares Held
21M
Call Options Held
10.4K
Put Options Held
2.3K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $227M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Krensavage Asset Management, LLC Portfolio

Follow Krensavage Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krensavage Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krensavage Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email